• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

Pharma Pulse 4/8/24: Rite Aid Announces Availability of Opill, List Prices for Pharmaceuticals in the US Compared to Other Countries & more


The latest news for pharma industry insiders.

Ed Schoonveld Discusses List Prices for Pharmaceuticals in the US Compared to Other Countries

In an interview with with Pharma Commerce Editor Nicholas Saraceno, Ed Schoonveld, Value and Access Advisor, Schoonveld Advisory and author of The Price of Global Health, explains why pharmaceutical products tend to cost more in the US than the rest of the world.

Navigating the Landscape of Cannabis Use in Oncology

Despite being a Schedule I drug, cannabis is increasingly used in oncology for symptom management, although data remains limited.

China Is Targeting US Voters and Taiwan With AI-Powered Disinformation

Findings from Microsoft and others shed light on Beijing’s expanding covert influence operations

Rite Aid Announces Availability of Opill at All Locations

The first FDA-approved over-the-counter daily birth control pill in the U.S. is now on shelves, available for purchase

Integrated DNA Technologies

IDT president Demaris Mills spoke with Pharmaceutical Executive about the state of #genomicmedicine and how IDT and Danaher Corporation are accelerating the real-life impact of tomorrow’s science and technology.

Read her interview here: https://bit.ly/3TDraNS

#genomics #CRISPR #geneediting

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs